Bodenhoff Mads

Track

Insider profile

Bodenhoff Mads's trades of Ascendis Pharma A/S's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
389.81
Quantity 2,440 +8.8%
Value US$4,593,162
Transaction date
Proposed sale
Price
415.89
Quantity 15,039
Value US$1,408,326
Transaction date
Proposed sale
Price
228.40
Quantity 91,562
Value US$2,247,810
Transaction date
Proposed sale
Price
242.09
Quantity 6,872
Value US$1,663,642
Transaction date
Proposed sale
Price
155.01
Quantity 2,254
Value US$349,403
Transaction date
Proposed sale
Price
152.12
Quantity 2,828
Value US$430,208
Transaction date
Proposed sale
Price
151.54
Quantity 2,225
Value US$337,170
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-08
S Sale
2,440 +8.8%
389.81
US$4,593,162 		2,440 +8.8% 389.81 US$4,593,162
2026-09-08 2026-09-08
PrS Proposed sale
15,039
415.89
US$1,408,326 		15,039 415.89 US$1,408,326
2026-03-06 2026-03-06
PrS Proposed sale
91,562
228.40
US$2,247,810 		91,562 228.40 US$2,247,810
2026-03-02 2026-03-02
PrS Proposed sale
6,872
242.09
US$1,663,642 		6,872 242.09 US$1,663,642
2025-03-05 2025-03-05
PrS Proposed sale
2,254
155.01
US$349,403 		2,254 155.01 US$349,403
2025-03-04 2025-03-04
PrS Proposed sale
2,828
152.12
US$430,208 		2,828 152.12 US$430,208
2024-03-07 2024-03-04
PrS Proposed sale
2,225
151.54
US$337,170 		2,225 151.54 US$337,170